Sinonasal teratocarcinosarcoma treated with surgery followed by volumetric modulated radiotherapy: a case report with review of literature

  • Tandon, Sarthak (Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre) ;
  • Gairola, Munish (Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre) ;
  • Ahlawat, Parveen (Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre) ;
  • Sharma, Kanika (Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre) ;
  • Barik, Soumitra (Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre) ;
  • Sachdeva, Nishtha (Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre) ;
  • Pasricha, Sunil (Department of Pathology, Rajiv Gandhi Cancer Institute and Research Centre) ;
  • Shenoy, Apeksha (Department of Radiology and Imaging, Rajiv Gandhi Cancer Institute and Research Centre)
  • Received : 2018.06.27
  • Accepted : 2018.10.02
  • Published : 2018.12.31


Surgical excision along with use of postoperative radiotherapy forms an integral management of sinonasal teratocarcinosarcoma (SNTCS). However, given the rarity of the tumor, no standardised guidelines, dose, technique and target delineation exist especially in the era of modern radiation delivery techniques. This is a case of 55-year-old male diagnosed as SNTCS treated with radical ethmoidectomy followed by volumetric modulated radiotherapy, showing good local control and acceptable toxicity profile.


  1. Agrawal N, Chintagumpala M, Hicks J, Eldin K, Paulino AC. Sinonasal teratocarcinosarcoma in an adolescent male. J Pediatr Hematol Oncol 2012;34:e304-7.
  2. Budrukkar A, Agarwal JP, Kane S, et al. Management and clinical outcome of sinonasal teratocarcinosarcoma: single institution experience. J Laryngol Otol 2010;124:739-43.
  3. Naik SM, Nanjundappa RH, Srihariprasad KS, Gupta S, Rao CR. Sinonasal teratocarcinosarcoma: a rare clinical entity managed by medial maxillectomy and adjuvant chemoradiation. Clin Rhinol Int J 2012;5:118-22.
  4. Shanmugaratnam K, Kunaratnam N, Chia KB, Chiang GS, Sinniah R. Teratoid carcinosarcoma of the paranasal sinuses. Pathology 1983;15:413-9.
  5. Heffner DK, Hyams VJ. Teratocarcinosarcoma (malignant teratoma?) of the nasal cavity and paranasal sinuses A clinicopathologic study of 20 cases. Cancer 1984;53:2140-54.<2140::AID-CNCR2820531025>3.0.CO;2-Y
  6. Smith SL, Hessel AC, Luna MA, Malpica A, Rosenthal DI, El-Naggar AK. Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients treated at a single institution and comparison with reported series. Arch Otolaryngol Head Neck Surg 2008;134:592-5.
  7. Carrizo F, Pineda-Daboin K, Neto AG, Luna MA. Pharyngeal teratocarcinosarcoma: review of the literature and report of two cases. Ann Diagn Pathol 2006;10:339-42.
  8. Pai SA, Naresh KN, Masih K, Ramarao C, Borges AM. Teratocarcinosarcoma of the paranasal sinuses: a clinicopathologic and immunohistochemical study. Hum Pathol 1998;29:718-22.
  9. Misra P, Husain Q, Svider PF, Sanghvi S, Liu JK, Eloy JA. Management of sinonasal teratocarcinosarcoma: a systematic review. Am J Otolaryngol 2014;35:5-11.
  10. Fatima SS, Minhas K, Din NU, Fatima S, Ahmed A, Ahmad Z. Sinonasal teratocarcinosarcoma: a clinicopathologic and immunohistochemical study of 6 cases. Ann Diagn Pathol 2013;17:313-8.
  11. Wei S, Carroll W, Lazenby A, Bell W, Lopez R, Said-Al-Naief N. Sinonasal teratocarcinosarcoma: report of a case with review of literature and treatment outcome. Ann Diagn Pathol 2008;12:415-25.
  12. Joshi A, Noronha V, Sharma M, et al. Neoadjuvant chemotherapy in advanced sinonasal teratocarcinosarcoma with intracranial extension: report of two cases with literature review. J Cancer Res Ther 2015;11:1003-5.
  13. Singh ND, Sen K, Sharma A, Bharadwaj M. Sinonasal teratocarcinosarcoma: is minimally invasive resection followed by adjuvant histology directed chemo-radiation a better alternative to radical excision? Case report. Int J Otorhinolaryngol Head Neck Surg 2017;3:452-4.
  14. Tokunaga T, Sunaga H, Kimura Y, Tsuda G, Fujieda S. A case of sinonasal teratocarcinosarcoma treated with surgery and post-operative intensity-modulated radiotherapy (IMRT). Auris Nasus Larynx 2012;39:641-5.
  15. Peng G, Ke Y, Wang T, Feng Y, Li Y, Wu G. Intensity-modulated radiotherapy for sinonasal teratocarcinosarcoma. J Huazhong Univ Sci Technolog Med Sci 2011;31:857-60.
  16. Foong YC, Murdolo V, Naiman N, Hepner L, Awad R. Sinonasal teratocarcinosarcoma: a case report. J Med Case Rep 2017;11:167.
  17. Sankaralingam M, Glegg M, Smith S, James A, Rizwanullah M. Quantitative comparison of volumetric modulated arc therapy and intensity modulated radiotherapy plan quality in sinonasal cancer. J Med Phys 2012;37:8-13.
  18. Nguyen K, Cummings D, Lanza VC, et al. A dosimetric comparative study: volumetric modulated arc therapy vs intensity-modulated radiation therapy in the treatment of nasal cavity carcinomas. Med Dosim 2013;38:225-32.
  19. Studenski MT, Bar-Ad V, Siglin J, et al. Clinical experience transitioning from IMRT to VMAT for head and neck cancer. Med Dosim 2013;38:171-5.
  20. Jeong Y, Lee SW, Kwak J, et al. A dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer. Radiat Oncol 2014;9:193.
  21. Guckenberger M, Richter A, Krieger T, Wilbert J, Baier K, Flentje M. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? Radiother Oncol 2009;93:259-65.
  22. Nitsche M, Hermann RM, Christiansen H, Berger J, Pradier O. Rationale for individualized therapy in Sinonasal Teratocarcinosarcoma (SNTC): case report. Onkologie 2005;28:653-6.